Brief: Enveric Biosciences Says Regains Compliance With Nasdaq Bid Price Rule
06/03/2025 16:30
March 6 (Reuters) - Enveric Biosciences Inc ENVB.O: ENVERIC BIOSCIENCES INC - REGAINS COMPLIANCE WITH NASDAQ BID PRICE RULE Source text: [ID:n0001493152-25-009336] Further company coverage: ENVB.O (((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003